Study: WAON therapy related to cardiovascular health

Veröffentlicht:

Von:

Referenz M. Sobajima, T. Nozawa, Y. Fukui et al. Die Waon-Therapie verbessert die Lebensqualität sowie die Herzfunktion und die Belastbarkeit bei Patienten mit chronischer Herzinsuffizienz. Int Herz J. 2015;56(2):203-208. Design Prospektive Kohorten-Pilotstudie Teilnehmer Neunundvierzig Krankenhauspatienten, die während eines unbestimmten Zeitraums nacheinander am Toyama University Hospital, Japan, eingeschrieben waren, wurden gemäß den Eignungskriterien für chronische Herzinsuffizienz (CHF) rekrutiert. Teilnehmer, die der Funktionsklasse II oder höher der New York Heart Association (NYHA) zugeordnet wurden, wurden eingeschlossen. Selbst wenn sie zuvor wegen Herzinsuffizienz ins Krankenhaus eingeliefert worden waren, wurde davon ausgegangen, dass sich alle in die Studie eingeschlossenen Teilnehmer in einem stabilen Zustand …
Reference M. Sobajima, T. Nozawa, Y. Fukui et al. WAON therapy improves the quality of life as well as heart function and resilience in patients with chronic heart failure. Int Herz J. 2015; 56 (2): 203-208. Design prospective cohort pilot study participant participants nine-end hospital patients who were registered one after the other at the Toyama University Hospital, Japan, were recruited in accordance with the aptitude criteria for chronic heart failure (CHF). Participants who were assigned to function class II or higher of the New York Heart Association (NYHA) were included. Even if they had previously been taken to the hospital for heart failure, it was assumed that all participants included in the study in a stable state ... (Symbolbild/natur.wiki)

Reference

m. Sobajima, T. Nozawa, Y. Fukui et al. WAON therapy improves the quality of life as well as heart function and resilience in patients with chronic heart failure.

Design

prospective cohort pilot study

participant

nine -to forty hospital patients who were enrolled one after the other at the Toyama University Hospital, Japan, who were registered one after the other during an indefinite period of time, were recruited in accordance with the aptitude criteria for chronic heart failure (CHF). Participants who were assigned to function class II or higher of the New York Heart Association (NYHA) were included. Even if they had previously been taken to the hospital for heart failure, it was assumed that all participants included in the study were in a stable state and that no intravenous medication received no intravenous medication at the time of admission. In the case of none of the study participants, medication was changed during the study period.
Twenty patients had ischemic cardiomyopathy and 29 patients of non-angry cardiomyopathy. More than 60 % of the patients were treated with beta blockers and 86 % with angiotensin-converting-enzyme inhibitors or angiotensin receptor blockers.

Intervention

WAON therapy (WT) was administered daily for 3 weeks. WT is a hyperthermal treatment in which the patients sit in a 60 degree C (140 degrees F) away infrared sauna for 15 minutes, followed by 30 minutes in a supine position, covered with warm blankets that are sufficient to increase the body temperature by 1.0 to 1.2 degrees C. Oral fluid intake was administered during and after therapy.

target parameter

The heart rate, blood pressure, blood pressure, body weight, NYHA class, specific activity scale (SAS), 6-minute walking test (6MWD), left ventricular ejection fraction (LVEF), left ventricular end systolic and diastolic measurements, left-wing atrial dimensions, blood and harness, creatinine, were measured High-density-lipoprotein and low-density-lipoprotein cholesterol, triglycerides, blood sugar, B-type/sodauretic peptide of the brain (BNP), plasma norepinephrine, natural killer cells (NK), river-mediated dilation (FMD), and life quality (QOL) Using the questionnaire Short Form Health Survey-36 (SF-36).

important knowledge

No patient showed a deterioration in clinical symptoms or suffered from complications due to WT, and no unwanted events were reported. WT significantly improved the NYHA function class, SAS and 6MWD, which are markers for the activity level and the stress tolerance. The LVEF and NK cell activity was light but significantly increased, and the plasma level from BNP was reduced according to WT. WT improved the vascular endothelial function, evaluated by FMD. Standard measurements were obtained using echocardiography.
The authors find that CHF patients had lower QOL scores in all components of SF-36 compared to the average scores of the general population of Japan. Three weeks WT significantly improved the physical components and the mental components of the SF-36, especially in the non-angry group. The restrictions of the study included that their long -term effects remain indefinite, the study sample was small and no randomization, blinding or control procedures were used.

practice implications

Although earlier studies were caution in sauna baths in relation to cardiovascular health, 1 New data have accumulated that indicate that patients with CHF can benefit from sauna. A recently carried out prospective cohort study with 2,315 men, which was carried out by a Finnish group of hearters and researchers, came to the conclusion that the sauna bath was associated with the risk of a fatal cardiovascular system (sudden heart disease) after a medium follow-up period of 20.7 years [CHD] cardiovascular disease [CVD]) and total mortality events 2 regardless of conventional risk factors. In particular, it was shown that men who went to the sauna 2 to 3 times a week had a 23 % lower risk of suffering a fatal episode of CHD or CVD than men who had 1 sauna per week. Men who went to the sauna 4 to 7 times a week had a 48 % lower risk. In this study, the participants were based on the frequency of the sauna bath (once/week, 2-3 times/week or 4-7 times/week) and according to the typical session (less than 11 min, 11-19 min or more than 20 min).
While many hospitals have cardiac rehabilitation centers that include physical and occupational therapies, only a few hospitals, if at all, have remote infrared saunas.
The sauna can increase the heart rate during sessions that correspond to a physical activity of medium intensity. 3.4 The sauna use has also shown a temporary increase in cardiac volume and heart frequency. and is often cited as a reason for the promotion of specific oral hydration regime. 5,9,10 Recent studies show us that repeated sauna treatment for CHF patients is secure and that it can specifically improve the endothelial function, the stress tolerance and the ejection fraction. Advantages in CHF patients.
The results of this pilot study indicate that WT is safe and can have psychological and physical advantages for CHF patients. The results that show an improvement in general QOL in addition to improving cardiac and vascular endothelial function and resilience are particularly encouraging. While many hospitals have cardiac rehabilitation centers that include physical and occupational therapies, only a few hospitals, if at all, have distant infrared saunas. In view of the abundance of studies, some patients could be interested in buying remote infrared saunas for home use. It is our responsibility to advise these patients on security issues regarding sauna therapy, especially if they have CHF or other chronic diseases. A clarification of the oral fluid intake and the limitation of the time spent during each session and the recommendation of security measures such as session timers would be a start.

  1. Giannetti N., Juneau M., Arsenault A. et al. Sauna -induced myocardiacalemia in patients with coronary heart disease. bin J med. 1999; 107 (3): 228-233.
  2. Laukkanen, T, Khan H, Zaccardi F, Laukkanen J. Association between sauna baths and fatal cardiovascular and overall mortality events. Jama internal med. 2015; 175 (4): 542-548.
  3. luurila abl. The sauna and the heart. j intern. 1992; 231 (4): 319-320.
  4. Kukkonen-Harjula K, Kauppinen K. Health effects and risks of the sauna bath. Int j circumpolar health. 2006; 65 (3): 195-205.
  5. Hasan J, Karvonen MJ, Piirons P. Special Review, I: Physiological effects of extreme heat, examined in the Finnish "Sauna" bath. bin j phys med. 1966; 45 (6): 296-314.
  6. Kukkonen-Harjula, K., Oja, P., Laustiola, K., et al. Hemodynamic and hormonal reactions to heat in a Finnish sauna bath. EUR J Appl Physiol Profession Physiol. 1989; 58 (5): 543-550.
  7. Hannussela ML, Ellahham S. Advantages and risks of the sauna bath. bin J med. February 1, 2001; 110 (2): 118-26.
  8. t. Kihara, S. Biro, Y. Ikeda et al. Effects of repeated sauna treatments on ventricular arrhythmias in patients with chronic heart failure. Kreis J. 2004; 68 (12): 1146-1151.
  9. chewpin K. sauna, shower and ice water diving: physiological reactions on short influences of heat, cold and cold. Part II. Transport. arctic med res. 1989; 48 (2): 64-74.
  10. vuori I. Circulation of the sauna adjacent. ann clinic res. 1988; 20 (4): 249-256.
  11. BASFORD JR, Oh JK, Allison TG, et al. Security, acceptance and physiological effects of sauna bath in people with chronic heart failure: a pilot report. Arch Phys med rehabil. 2009; 90 (1): 173-177.
  12. t. Ohori, T. Nozawa, H. Ihori et al. Effect of repeated sauna treatment on the stress tolerance and the endothelial function in patients with chronic heart failure. am J Cardiol. 2012; 109 (1): 100-104.
  13. t. Kihara, S. Biro, M. Imamura et al. Repeated sauna treatment improves the vascular endothelic and heart function in patients with chronic heart failure. j am Coll Cardiol. 2002; 39 (5): 754-759.
  14. m. Sobajima, T. Nozawa, H. Ihori et al. Repeated sauna therapy improves myocardial perfusion in patients with chronically closed coronary artery-associated ischemia. int. J. Cardiol. 2013; 167 (1): 237-243.